Stories from the Front Lines of Regenerative Care
Whether you’re a pet parent, veterinary professional, clinical trial partner, or member of the media—thanks for reaching out.
Read what BioSpace had to say about our pivotal study of allogeneic stem cell therapy targeting feline chronic gingivostomatitis (FCGS), a painful and debilitating disease in cats.
Gallant is redefining veterinary medicine with ready-to-use stem cell therapies that reduce inflammation, restore function, and fit seamlessly into everyday practice.
